The US Optical Coherence Tomography Market is expanding as healthcare providers increasingly adopt advanced, non-invasive diagnostic imaging technologies. The market was valued at USD 377.3 million in 2024 and is projected to reach USD 830.15 million by 2035, growing at a CAGR of 7.43% during 2025–2035. Rising demand for precise imaging and early disease detection is supporting this growth.

Technological advancements are improving the resolution, speed, and overall performance of OCT systems. The integration of artificial intelligence and machine learning is also creating opportunities for faster image analysis and more efficient clinical workflows. Increasing demand for non-invasive diagnostic procedures is encouraging healthcare providers to adopt advanced OCT technologies.

Ophthalmology remains the largest application segment, supported by the increasing prevalence of conditions such as diabetic retinopathy, glaucoma, and age-related macular degeneration. Cardiology is identified as the fastest-growing application segment. By technology, SD-OCT currently dominates, while swept-source OCT is gaining momentum because of its advanced imaging capabilities.

The future of the U.S. OCT market is likely to be shaped by AI-powered diagnostics, portable imaging devices, telemedicine integration, and continued healthcare infrastructure investment. Leading companies such as Carl Zeiss AG, Topcon Corporation, Heidelberg Engineering, Nidek, Optovue, Tomey, Canon, and Santec are contributing to technological development and competition.

Understand industry shifts with well-researched analysis:

Liquid Biopsy Market Volume

Liquid Biopsy Market Forecast

Liquid Biopsy Market Outlook

Liquid Biopsy Market Analysis

Active Adult Community Market Distribution